NORDEA INVESTMENT MANAGEMENT AB
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1218210
STOCKHOLM, V7
Position in LGND
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$10,169,371
+$11,586 QoQ
Shares Held
50,936
-5.2% QoQ
Ownership
0.254%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORDEA INVESTMENT MANAGEMENT AB holds $224,709,274 across 23 Biotechnology names. LGND ranks #5 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
94,322 | $72,876,949 | |
| 2 | RPRX |
Royalty Pharma plc
|
788,022 | $37,801,414 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
306,439 | $19,213,724 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
27,171 | $12,132,937 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
This page
|
50,936 | $10,169,371 | |
| 6 | EXEL |
Exelixis, Inc.
|
201,553 | $8,644,607 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
113,902 | $6,434,323 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
51,821 | $5,461,932 |
All Filings in LGND
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,169,371 | 50,936 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $10,157,785 | 53,725 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $10,805,716 | 61,001 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $6,668,468 | 58,660 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $6,164,568 | 58,632 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $6,275,988 | 58,572 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $5,565,203 | 55,602 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $4,945,977 | 58,699 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $4,994,776 | 68,328 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $4,925,908 | 68,971 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $4,275,411 | 71,352 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,201,870 | 72,148 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $5,270,059 | 71,643 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $4,934,716 | 73,873 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $3,757,036 | 69,940 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $3,905,807 | 70,175 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $5,076,648 | 72,343 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $6,883,344 | 71,436 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $6,254,795 | 71,967 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $5,979,579 | 73,064 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $6,172,939 | 64,908 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,105,738 | 66,179 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,469,875 | 41,536 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $5,758,562 | 82,530 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,863,635 | 41,081 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||